CapsoVision, Inc. (CV) has filed to raise $27.6 million in an IPO of its common stock, according to SEC S-1/A registration information. CV is developing and commercializing imaging devices and related ...
Top-Line Results Show Lyrica Met All Co-Primary Endpoints NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study for Lyrica (pregabalin) in patients with Restless Legs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results